Neurointerventional Devices Market in Demand: Sentiment is Shifting Towards Growth | Codman & Shurtleff, Integra Life Sciences, Medtronic, Stryker, Boston Scientific, BrainLab, Elekta, Karl Storz, Micromar

Neurointerventional devices are advanced medical specialty instrument that uses minimally invasive endovascular techniques. This device is used during minimally invasive surgery during the treatment of vascular diseases of the brain. The neuro intervention is a medical condition that is basically occurring inside the spinal cavity or vessels of the brain. Neurointervention is gaining huge demand amongst neuro-specialists due to its minimal invasiveness nature and neuro intervention also has a significant success rate.

Inquire for a sample copy of this report @ https://www.stratagemmarketinsights.com/sample/8918

Growing cases of stroke and aneurysm in the U.S. region is projected to foster the market growth of Neurointerventional devices. According to the Brain Aneurysm Foundation, an estimated 6.5 million people in the United States have an unruptured brain aneurysm or 1 in 50 people. Increasing focus of manufacturers to introduce advanced technology and expand their presence in the U.S. market is further estimated to foster the market growth of neurointerventional devices. For instance, in July 2017, Johnson & Johnson Medical Devices Companies introduced CERENOVUS, its new neurovascular business, at the Society of NeuroInterventional Surgery (SNIS) 14th Annual Meeting in Colorado. CERENOVUS will focus on offering innovative therapies for hemorrhagic and ischemic stroke patients.

Key Developments:

In July 2019, Penumbra announced U.S. commercial availability of the Penumbra System’s advanced technology, the Penumbra Jet 7 Reperfusion Catheter with Xtra Flex technology, at the Society of NeuroInterventional Surgery (SNIS) 16th Annual Meeting.

In Luly 2018, MicroVention, Inc. a U.S.-based subsidiary of Terumo and a neurovascular company, announced the FDA clearance of a new clinical indication for the SOFIA® Catheter (Soft TOrqueable catheter For Intracranial Access) to include contact aspiration technique for successful revascularization among patients with acute ischemic stroke, secondary to intracranial large vessel occlusive disease.

In October 2017, Vesalio announces the CE Mark certification of its first product line, the proprietary NeVa™ neuro thrombectomy platform for the treatment of strokes.

In July 2019, Medtronic and Viz.ai have partnered to promote the adoption of Viz.ai’s new technology, which helps to synchronize stroke care and decrease time to treatment, potentially improving outcomes for patients. Viz.ai’s technology uses artificial intelligence (AI) to identify suspected large vessel occlusion (LVO) strokes and automatically notify specialists.

In October 2017, Johnson & Johnson aquired Codman Neurosurgery business to Integra LifeSciences Holding Corporation for an approximate value of $1.045 billion. The Codman Neurosurgery business provide a portfolio of devices focused on hydrocephalus management, neurointensive care, and cranial surgery, and generated net revenues of approximately $371.5 million in 2016.

Geographically, this report splits the United States market into seven regions:
╼ The West
╼ Southwest
╼ The Middle Atlantic
╼ New England
╼ The South
╼ The Midwest

with sales (volume), revenue (value), market share and growth rate of Neurointerventional Devices in these regions, from 2014 to 2025 (forecast).

United States Neurointerventional Devices market competition by top manufacturers/players, with Neurointerventional Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
╼ Codman & Shurtleff
╼ Integra Life Sciences
╼ Medtronic
╼ Stryker
╼ Boston Scientific
╼ BrainLab
╼ Elekta
╼ Karl Storz
╼ Micromar
╼ Scopis
╼ SPR Therapeutics
╼ St. Jude Medical
╼ Synapse Biomedical
╼ Aesculap(B.Braun)
╼ TeDan Surgical Innovations
╼ Kogent Surgical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

╼ Embolic Coils
╼ Neurovascular Stents (Carotid Stents and Intracranial Stents)
╼ Neurovascular Thrombectomy Devices
╼ Intrasaccular Devices
╼ Embolic Protection Devices
╼ Others

To Access and buy a Complete Report @
https://www.stratagemmarketinsights.com/cart/8918

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Neurointerventional Devices for each application, including

╼ Hospitals
╼ Ambulatory Surgical Centers
╼ Others

** If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Us:
Mr. Shah
Stratagem Market Insights
Tel: US +1 415 871 0703 / JAPAN +81-50-5539-1737
Email: sales@stratagemmarketinsights.com
Explore By- SK

About Stratagem Market Insights:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with an cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our reports cover various end-use industries such as Aerospace and Defense, Agriculture, Food and Beverages, Automotive, Chemicals and Materials, Consumer Goods and Retail, Electronics, Energy, Mining, and Utilities, Pharmaceuticals, Manufacturing and Construction, Services, and Healthcare, and ICT.

This release was published on openPR.